These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 30400055)

  • 1. French Endocrine Society Guidance on endocrine side effects of immunotherapy.
    Castinetti F; Albarel F; Archambeaud F; Bertherat J; Bouillet B; Buffier P; Briet C; Cariou B; Caron P; Chabre O; Chanson P; Cortet C; Do Cao C; Drui D; Haissaguerre M; Hescot S; Illouz F; Kuhn E; Lahlou N; Merlen E; Raverot V; Smati S; Verges B; Borson-Chazot F
    Endocr Relat Cancer; 2019 Feb; 26(2):G1-G18. PubMed ID: 30400055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy-induced endocrinopathies: Insights from the 2018 French Endocrine Society Guidelines].
    Castinetti F; Borson-Chazot F
    Bull Cancer; 2019 May; 106(5):492-496. PubMed ID: 30981462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.
    Chang LS; Barroso-Sousa R; Tolaney SM; Hodi FS; Kaiser UB; Min L
    Endocr Rev; 2019 Feb; 40(1):17-65. PubMed ID: 30184160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitors and endocrine side effects, a narrative review.
    Agrawal L; Bacal A; Jain S; Singh V; Emanuele N; Emanuele M; Meah F
    Postgrad Med; 2020 Mar; 132(2):206-214. PubMed ID: 31876444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to expert opinion on endocrine complications of new anticancer therapies.
    Castinetti F; Borson-Chazot F
    Ann Endocrinol (Paris); 2018 Oct; 79(5):535-538. PubMed ID: 30056976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions.
    Castinetti F; Albarel F; Archambeaud F; Bertherat J; Bouillet B; Buffier P; Briet C; Cariou B; Caron P; Chabre O; Chanson P; Cortet C; Do Cao C; Drui D; Haissaguerre M; Hescot S; Illouz F; Kuhn E; Lahlou N; Merlen E; Raverot V; Smati S; Verges B; Borson-Chazot F
    Ann Endocrinol (Paris); 2018 Oct; 79(5):591-595. PubMed ID: 30056975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine immune-related adverse effects of immune-checkpoint inhibitors.
    Trevisani V; Iughetti L; Lucaccioni L; Predieri B
    Expert Rev Endocrinol Metab; 2023; 18(5):441-451. PubMed ID: 37682107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endocrinopathies induced by immune checkpoint inhibitors].
    Jaafar J; Mavromati M; Philippe J
    Rev Med Suisse; 2018 Jan; 14(588-589):34-38. PubMed ID: 29337446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How we treat endocrine complications of immune checkpoint inhibitors.
    Paschou SA; Stefanaki K; Psaltopoulou T; Liontos M; Koutsoukos K; Zagouri F; Lambrinoudaki I; Dimopoulos MA
    ESMO Open; 2021 Feb; 6(1):100011. PubMed ID: 33399077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary and adrenal disorders induced by immune checkpoint inhibitors.
    Albarel F; Brue T; Castinetti F
    Ann Endocrinol (Paris); 2023 May; 84(3):339-345. PubMed ID: 36965852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endocrinopathies Associated with Immune Checkpoint Inhibitors].
    Santos MJ
    Acta Med Port; 2022 Mar; 35(3):209-215. PubMed ID: 35077347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists.
    Illouz F; Briet C; Cloix L; Le Corre Y; Baize N; Urban T; Martin L; Rodien P
    Cancer Med; 2017 Aug; 6(8):1923-1929. PubMed ID: 28719055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine, Sexual Function, and Infertility Side Effects of Immune Checkpoint Inhibitor Therapy for Genitourinary Cancers.
    Sood A; Cole D; Abdollah F; Eilender B; Roumayah Z; Deebajah M; Dabaja A; Alanee S
    Curr Urol Rep; 2018 Jul; 19(9):68. PubMed ID: 29971696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system.
    Zhai Y; Ye X; Hu F; Xu J; Guo X; Zhuang Y; He J
    J Immunother Cancer; 2019 Nov; 7(1):286. PubMed ID: 31694698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine side effects induced by immune checkpoint inhibitors.
    Corsello SM; Barnabei A; Marchetti P; De Vecchis L; Salvatori R; Torino F
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1361-75. PubMed ID: 23471977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine dysfunction induced by immune checkpoint inhibitors.
    Deligiannis NG; Sosa S; Danilowicz K; Rizzo LFL
    Medicina (B Aires); 2021; 81(2):269-278. PubMed ID: 33906146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians.
    Hryniewicki AT; Wang C; Shatsky RA; Coyne CJ
    J Emerg Med; 2018 Oct; 55(4):489-502. PubMed ID: 30120013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know).
    Ruggeri RM; Campennì A; Giuffrida G; Trimboli P; Giovanella L; Trimarchi F; Cannavò S
    J Endocrinol Invest; 2019 Jul; 42(7):745-756. PubMed ID: 30471004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database.
    Sato K; Mano T; Iwata A; Toda T
    J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine side effects of cancer immunotherapy.
    Cukier P; Santini FC; Scaranti M; Hoff AO
    Endocr Relat Cancer; 2017 Dec; 24(12):T331-T347. PubMed ID: 29025857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.